This report compares expenditure between primary and secondary care in total and for medicines positively appraised by NICE.
Prescribing Costs in Hospitals and the Community, England 2014/15
This is part of Prescribing Costs in Hospitals and the CommunityOfficial statistics
- Publication date:
- 12 Nov 2015
- Geographic coverage:
- Geographical granularity:
- Country, Regions
- Date range:
- 01 Apr 2014 to 31 Mar 2015
The overall NHS expenditure on medicines in 2014-15 was £15.5 billion, an increase of 7.8 per cent from £14.4 billion in 2013-14 and an increase of 19.4 per cent from £13.0 billion in 2010-11.
In 2014-15 hospital use accounted for 42.9 per cent of the total cost, up from 40.1 per cent in 2013-14 and up from 32.1 per cent in 2010/11.
The cost of medicines rose by 7.8 per cent overall but by 15.4 per cent in hospitals, from 2013-14 to 2014-15. The cost of medicines in hospitals has risen by 59.8 per cent since 2010-11.
Of the drugs positively appraised by NICE, the greatest overall cost in 2014-15 was for Adalimumab (£371.2m), which also incurred the greatest cost (over £348.2 million) in hospitals.